The move signals renewed conviction in next-generation gene-editing technology
On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics (NTLA), scooping up 145,153 shares in the gene-editing play.
For the most part, it has been a forgettable year for Intellia stock, cl… [6972 chars]
Source: The Street | Published: 2025-12-31T15:33:00Z
Credit: The Street
